UBS Maintains a 'Buy' on Nike (NKE); Rare Miss; Sees Stronger Execution
Tweet Send to a FriendGet Alerts NKE Hot Sheet
Price: $61.75 --0%
Rating Summary:
14 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 16
Rating Summary:
14 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 16
Trade NKE Now!
UBS maintains a 'Buy' on Nike (NYSE: NKE) price target of $99.00 (from $125.00).
Analyst, Michael Binetti, said, "Nike's stock has increased by +6%, +15% and +27% in the 3-mos, 6-mos and 12-mos periods following prior EPS disappointments on avg. In our view, Nike’s execution has actually improved in recent qtrs, even though fundamentals will be under pressure from worsening global macro and unfavorable FX shifts in the near-term."
UBS lowers FY13 from $5.85 to $5.26 and FY14 from $6.74 to $6.05.
For an analyst ratings summary and ratings history on Nike click here. For more ratings news on Nike click here.
Shares of Nike closed at $96.89 yesterday, with a 52 week range of $76.98-$114.81.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Michael Binetti, said, "Nike's stock has increased by +6%, +15% and +27% in the 3-mos, 6-mos and 12-mos periods following prior EPS disappointments on avg. In our view, Nike’s execution has actually improved in recent qtrs, even though fundamentals will be under pressure from worsening global macro and unfavorable FX shifts in the near-term."
UBS lowers FY13 from $5.85 to $5.26 and FY14 from $6.74 to $6.05.
For an analyst ratings summary and ratings history on Nike click here. For more ratings news on Nike click here.
Shares of Nike closed at $96.89 yesterday, with a 52 week range of $76.98-$114.81.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jefferies Boosts PT on Micron (MU) Post Q3; Sees 50% Upside
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
- JPMorgan Downgrades FedEx (FDX) to Neutral
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBS
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
